Adherence to CLSI recommendations for testing of Staphylococcus aureus isolates in Louisiana hospitals: Report of a clinical failure and results of a questionnaire study

Journal of Clinical Microbiology

Volumn 49, Issue 8, 2011, Pages 3019-3020

  Patra, Kamakshya P ^a   Vanchiere, John A ^a   Bocchini Jr , Joseph A ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CASE REPORT; CELLULITIS; CHILD; CLINICAL LABORATORY; CLINICAL PROTOCOL; DISEASE EXACERBATION; DISK DIFFUSION; DOUBLE DISK DIFFUSION TEST; DRUG TREATMENT FAILURE; ECZEMA; FEMALE; FOLLOW UP; HEALTH CARE SURVEY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; SKIN CULTURE; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STRUCTURED QUESTIONNAIRE; TREATMENT DURATION; UNITED STATES;

ANTI-BACTERIAL AGENTS; CHILD; CLINDAMYCIN; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; LOUISIANA; MICROBIAL SENSITIVITY TESTS; QUESTIONNAIRES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE;

STAPHYLOCOCCUS AUREUS;

EID: 79960950114     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00944-11     Document Type: Article

References (12)

1. Chambers, H. F. 2006. Protein synthesis inhibitors and miscellaneous antibacterial agents, p. 1188-1190. In L. L. Brunton, J. S. Lazo, and K. L. Parker, Goodman & Gilman's the pharmacological basis of therapeutics, 11th ed. McGraw-Hill Publishers, New York, NY.
2. Chavez-Bueno, S., et al. 2005. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob. Agents Chemother. 49:2283-2288.
3. Daurel, C., et al. 2008. Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes. J. Clin. Microbiol. 46:546-550.
4. Fiebelkorn, K. R., S. A. Crawford, M. L. McElmeel, and J. H. Jorgensen. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41:4740-4744.
5. Frank, A. L., et al. 2002. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21:530-533.
6. Hersh, A. L., M. D. Cabana, R. Gonzales, B. N. Shenkin, and C. S. Cho. 2009. Pediatricians' perspectives on the impact of MRSA in primary care: a qualitative study. BMC Pediatr. 9:27.
7. Islam, Z., and R. C. Ratard. 2008. Trends in Antibiotic Resistance in Louisiana - 2008. Office of Public Health, Louisiana Department of Health and Hospitals, Baton Rouge, LA.
8. NCCLS. 2004. Performance standards for antimicrobial susceptibility testing, 14th informational supplement. NCCLS document M100-S14. National Committee for Clinical Laboratory Standards, Wayne, PA.
9. Patel, M., K. B. Waites, S. A. Moser, G. A. Cloud, and C. J. Hoesley. 2006. Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates. J. Clin. Microbiol. 44:2481-2484.
10. Rao, G. G. 2000. Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J. Antimicrob. Agents Chemother. 45:715.
11. Sattler, C. A., E. O. Mason, and S. L. Kaplan. 2002. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr. Infect. Dis. J. 21:910-916.
12. Siberry, G. K., et al. 2003. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 37:1257-1260.